Home / Latest Reports / Biobanks Market

Biobanks Market by Type, Application, End User, Key Players and Regions - Global Industry Analysis & Forecast to 2027

Published On : August 2022 Pages : 182 Category: Pharma & Healthcare Report Code : HC0817400

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

The global Biobanks Market is valued at USD XX billion in 2021 and is projected to reach USD XX billion by the end of 2027, growing at a CAGR of XX% during the period 2022 to 2027.

The report exhibit detail coverage of Biobanks industry and market trends. The report also analyses present and past market values to forecast potential market through the forecast period between 2017-2022. This research study of Biobanks Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

In addition, the report provides insight into main drivers, challenges, opportunities and risk of the market and strategies of suppliers. Key players are profiled as well. Overall, this report covers the historical situation, present status and the future prospects of the global Biobanks Market for 2017-2022.

Crystal Market Research envisions that the span of the Biobanks Market will develop amid the estimated time frame as the Compound Annual Growth Rate boosts significantly. The objective of the market research report is the current status of the market and in accordance classifies it into a few portions. The report takes into consideration the prime market players in every area from over the globe.

Our research study analyses the size of the global market of Biobanks in primary regions such as North America, South America, Middle East & Africa, Asia Pacific and Europe. It also classifies the Biobanks Market by key manufacturers, region, type and application. Furthermore, this study examines in the status of the market, market share, future trends, growth rate, competitive landscape, opportunities, market driving factors and restraints, and challenges.

To stay updated with the latest technology and functions of the industry, Crystal Market Research regularly performs interviews with several industry experts and visits for its expert research analysts. The data sources include but not limited to reports of company’s, international organizations and governments, MMI market surveys, and related industry news.

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2027. This report has segmented the Biobanks Market on the basis of fabric, product, application, and region:

By Region

  • North America (US, Canada)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Mexico, Columbia, Rest of South America)
  • Middle East and Africa (Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA)

Competitive Analysis                    

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • QIAGEN
  • Hamilton Company
  • Avantor
  • Tecan Trading AG
  • Danaher Corporation
  • Becton, Dickinson and Company (BD)
  • BioCision
  • Taylor-Wharton
  • Charles River Laboratories
  • Lonza
  • STEMCELL Technologies Inc.
  • Biovault Family
  • PromoCell GmbH
  • Precision Cellular Storage Ltd.

Market Classification

·        Biobanks Market, By Type, Estimates and Forecast, 2017-2022 ($Million)

o   Blood Products

o   Solid Tissue

o   Cell Lines

o   Nucleic Acid

o   Others

·        Biobanks Market, By Application, Estimates and Forecast, 2017-2022 ($Million)

o   Therapeutic

o   Drug Discovery & Clinical Research

o   Clinical Diagnostics

o   Others

·        Biobanks Market, By End User, Estimates and Forecast, 2017-2022 ($Million)

o   Academic Institutions

o   Pharma & Biotech Companies

o   Others

Table of Contents

1.     Introduction

1.1.  Report Description

1.2.  Research Methodology

1.2.1.     Data Mining

1.2.2.     Market Modeling and Forecasting

1.2.3.     Data Validation

1.2.4.     Industry Analysis

2.     Market Dashboard

3.     Market Overview

3.1.  Introduction

3.1.1.     Market Definition

3.1.2.     Market Segmentation

3.2.  Market Dynamics

3.2.1.     Drivers

3.2.2.     Restraints

3.2.3.     Opportunities

3.2.4.     Challenges

4.     Biobanks Market, By Type

4.1.  Introduction

4.2.  Biobanks Market and Market Growth Rate By Type (2017-2022)

4.3.  Blood Products

4.3.1.     Global Blood Products Market and Growth Rate (2017-2022)

4.3.  Solid Tissue

4.3.1.     Global Solid Tissue Market and Growth Rate (2017-2022)

4.3.  Cell Lines

4.3.1.     Global Cell Lines Market and Growth Rate (2017-2022)

4.3.  Nucleic Acid

4.3.1.     Global Nucleic Acid Market and Growth Rate (2017-2022)

4.3.  Others

4.3.1.     Global Others Market and Growth Rate (2017-2022)

5.     Biobanks Market, By Application

5.1.  Introduction

5.2.  Biobanks Market and Market Growth Rate By Application (2017-2022)

5.3.  Therapeutic

5.3.1.     Global Therapeutic Market and Growth Rate (2017-2022)

5.3.  Drug Discovery & Clinical Research

5.3.1.     Global Drug Discovery & Clinical Research Market and Growth Rate (2017-2022)

5.3.  Clinical Diagnostics

5.3.1.     Global Clinical Diagnostics Market and Growth Rate (2017-2022)

5.3.  Others

5.3.1.     Global Others Market and Growth Rate (2017-2022)

6.     Biobanks Market, By End User

6.1.  Introduction

6.2.  Biobanks Market and Market Growth Rate By End User (2017-2022)

6.3.  Academic Institutions

6.3.1.     Global Academic Institutions Market and Growth Rate (2017-2022)

6.3.  Pharma & Biotech Companies

6.3.1.     Global Pharma & Biotech Companies Market and Growth Rate (2017-2022)

6.3.  Others

6.3.1.     Global Others Market and Growth Rate (2017-2022)

7.     Biobanks Market, By Region

7.1.  Introduction

7.2.  Biobanks Market and Growth Rate By Regions

6.3.  North America

7.3.1.     North America Biobanks Market and Growth Rate (2017-2022))

7.3.2.     North America Biobanks Market By Type (2017-2022)

7.3.2.     North America Biobanks Market By Application (2017-2022)

7.3.2.     North America Biobanks Market By End User (2017-2022)

7.3.4.     North America Biobanks Market By Country (2017-2022)

7.3.5.     United States

7.3.5.1.United States Biobanks Market and Growth Rate (2017-2022)

7.3.5.2.United States Biobanks Market By Type (2017-2022)

7.3.5.2.United States Biobanks Market By Application (2017-2022)

7.3.5.2.United States Biobanks Market By End User (2017-2022)

7.3.5.     Canada

7.3.5.1.Canada Biobanks Market and Growth Rate (2017-2022)

7.3.5.2.Canada Biobanks Market By Type (2017-2022)

7.3.5.2.Canada Biobanks Market By Application (2017-2022)

7.3.5.2.Canada Biobanks Market By End User (2017-2022)

6.3.  Europe

8.3.1.     Europe Biobanks Market and Growth Rate (2017-2022))

8.3.2.     Europe Biobanks Market By Type (2017-2022)

8.3.2.     Europe Biobanks Market By Application (2017-2022)

8.3.2.     Europe Biobanks Market By End User (2017-2022)

8.3.4.     Europe Biobanks Market By Country (2017-2022)

8.3.5.     Germany

8.3.5.1.Germany Biobanks Market and Growth Rate (2017-2022)

8.3.5.2.Germany Biobanks Market By Type (2017-2022)

8.3.5.2.Germany Biobanks Market By Application (2017-2022)

8.3.5.2.Germany Biobanks Market By End User (2017-2022)

8.3.5.     France

8.3.5.1.France Biobanks Market and Growth Rate (2017-2022)

8.3.5.2.France Biobanks Market By Type (2017-2022)

8.3.5.2.France Biobanks Market By Application (2017-2022)

8.3.5.2.France Biobanks Market By End User (2017-2022)

8.3.5.     UK

8.3.5.1.UK Biobanks Market and Growth Rate (2017-2022)

8.3.5.2.UK Biobanks Market By Type (2017-2022)

8.3.5.2.UK Biobanks Market By Application (2017-2022)

8.3.5.2.UK Biobanks Market By End User (2017-2022)

8.3.5.     Russia

8.3.5.1.Russia Biobanks Market and Growth Rate (2017-2022)

8.3.5.2.Russia Biobanks Market By Type (2017-2022)

8.3.5.2.Russia Biobanks Market By Application (2017-2022)

8.3.5.2.Russia Biobanks Market By End User (2017-2022)

8.3.5.     Italy

8.3.5.1.Italy Biobanks Market and Growth Rate (2017-2022)

8.3.5.2.Italy Biobanks Market By Type (2017-2022)

8.3.5.2.Italy Biobanks Market By Application (2017-2022)

8.3.5.2.Italy Biobanks Market By End User (2017-2022)

8.3.5.     Rest of Europe

8.3.5.1.Rest of Europe Biobanks Market and Growth Rate (2017-2022)

8.3.5.2.Rest of Europe Biobanks Market By Type (2017-2022)

8.3.5.2.Rest of Europe Biobanks Market By Application (2017-2022)

8.3.5.2.Rest of Europe Biobanks Market By End User (2017-2022)

6.3.  Asia-Pacific

9.3.1.     Asia-Pacific Biobanks Market and Growth Rate (2017-2022))

9.3.2.     Asia-Pacific Biobanks Market By Type (2017-2022)

9.3.2.     Asia-Pacific Biobanks Market By Application (2017-2022)

9.3.2.     Asia-Pacific Biobanks Market By End User (2017-2022)

9.3.4.     Asia-Pacific Biobanks Market By Country (2017-2022)

9.3.5.     China

9.3.5.1.China Biobanks Market and Growth Rate (2017-2022)

9.3.5.2.China Biobanks Market By Type (2017-2022)

9.3.5.2.China Biobanks Market By Application (2017-2022)

9.3.5.2.China Biobanks Market By End User (2017-2022)

9.3.5.     Japan

9.3.5.1.Japan Biobanks Market and Growth Rate (2017-2022)

9.3.5.2.Japan Biobanks Market By Type (2017-2022)

9.3.5.2.Japan Biobanks Market By Application (2017-2022)

9.3.5.2.Japan Biobanks Market By End User (2017-2022)

9.3.5.     Korea

9.3.5.1.Korea Biobanks Market and Growth Rate (2017-2022)

9.3.5.2.Korea Biobanks Market By Type (2017-2022)

9.3.5.2.Korea Biobanks Market By Application (2017-2022)

9.3.5.2.Korea Biobanks Market By End User (2017-2022)

9.3.5.     India

9.3.5.1.India Biobanks Market and Growth Rate (2017-2022)

9.3.5.2.India Biobanks Market By Type (2017-2022)

9.3.5.2.India Biobanks Market By Application (2017-2022)

9.3.5.2.India Biobanks Market By End User (2017-2022)

9.3.5.     Southeast Asia

9.3.5.1.Southeast Asia Biobanks Market and Growth Rate (2017-2022)

9.3.5.2.Southeast Asia Biobanks Market By Type (2017-2022)

9.3.5.2.Southeast Asia Biobanks Market By Application (2017-2022)

9.3.5.2.Southeast Asia Biobanks Market By End User (2017-2022)

9.3.5.     Rest of Asia-Pacific

9.3.5.1.Rest of Asia-Pacific Biobanks Market and Growth Rate (2017-2022)

9.3.5.2.Rest of Asia-Pacific Biobanks Market By Type (2017-2022)

9.3.5.2.Rest of Asia-Pacific Biobanks Market By Application (2017-2022)

9.3.5.2.Rest of Asia-Pacific Biobanks Market By End User (2017-2022)

6.3.  South America

10.3.1.     South America Biobanks Market and Growth Rate (2017-2022))

10.3.2.     South America Biobanks Market By Type (2017-2022)

10.3.2.     South America Biobanks Market By Application (2017-2022)

10.3.2.     South America Biobanks Market By End User (2017-2022)

10.3.4.     South America Biobanks Market By Country (2017-2022)

10.3.5.     Brazil

10.3.5.1.Brazil Biobanks Market and Growth Rate (2017-2022)

10.3.5.2.Brazil Biobanks Market By Type (2017-2022)

10.3.5.2.Brazil Biobanks Market By Application (2017-2022)

10.3.5.2.Brazil Biobanks Market By End User (2017-2022)

10.3.5.     Mexico

10.3.5.1.Mexico Biobanks Market and Growth Rate (2017-2022)

10.3.5.2.Mexico Biobanks Market By Type (2017-2022)

10.3.5.2.Mexico Biobanks Market By Application (2017-2022)

10.3.5.2.Mexico Biobanks Market By End User (2017-2022)

10.3.5.     Columbia

10.3.5.1.Columbia Biobanks Market and Growth Rate (2017-2022)

10.3.5.2.Columbia Biobanks Market By Type (2017-2022)

10.3.5.2.Columbia Biobanks Market By Application (2017-2022)

10.3.5.2.Columbia Biobanks Market By End User (2017-2022)

10.3.5.     Rest of South America

10.3.5.1.Rest of South America Biobanks Market and Growth Rate (2017-2022)

10.3.5.2.Rest of South America Biobanks Market By Type (2017-2022)

10.3.5.2.Rest of South America Biobanks Market By Application (2017-2022)

10.3.5.2.Rest of South America Biobanks Market By End User (2017-2022)

6.3.  Middle East and Africa

11.3.1.     Middle East and Africa Biobanks Market and Growth Rate (2017-2022))

11.3.2.     Middle East and Africa Biobanks Market By Type (2017-2022)

11.3.2.     Middle East and Africa Biobanks Market By Application (2017-2022)

11.3.2.     Middle East and Africa Biobanks Market By End User (2017-2022)

11.3.4.     Middle East and Africa Biobanks Market By Country (2017-2022)

11.3.5.     Saudi Arabia

11.3.5.1.Saudi Arabia Biobanks Market and Growth Rate (2017-2022)

11.3.5.2.Saudi Arabia Biobanks Market By Type (2017-2022)

11.3.5.2.Saudi Arabia Biobanks Market By Application (2017-2022)

11.3.5.2.Saudi Arabia Biobanks Market By End User (2017-2022)

11.3.5.     United Arab Emirates

11.3.5.1.United Arab Emirates Biobanks Market and Growth Rate (2017-2022)

11.3.5.2.United Arab Emirates Biobanks Market By Type (2017-2022)

11.3.5.2.United Arab Emirates Biobanks Market By Application (2017-2022)

11.3.5.2.United Arab Emirates Biobanks Market By End User (2017-2022)

11.3.5.     South Africa

11.3.5.1.South Africa Biobanks Market and Growth Rate (2017-2022)

11.3.5.2.South Africa Biobanks Market By Type (2017-2022)

11.3.5.2.South Africa Biobanks Market By Application (2017-2022)

11.3.5.2.South Africa Biobanks Market By End User (2017-2022)

11.3.5.     Rest of Middle East and Africa

11.3.5.1.Rest of Middle East and Africa Biobanks Market and Growth Rate (2017-2022)

11.3.5.2.Rest of Middle East and Africa Biobanks Market By Type (2017-2022)

11.3.5.2.Rest of Middle East and Africa Biobanks Market By Application (2017-2022)

11.3.5.2.Rest of Middle East and Africa Biobanks Market By End User (2017-2022)

7.     Company Profiles

7.1.  Thermo Fisher Scientific, Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Merck KGaA

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  QIAGEN

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Hamilton Company

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Avantor

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Tecan Trading AG

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Danaher Corporation

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Becton, Dickinson and Company (BD)

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  BioCision

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Taylor-Wharton

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Charles River Laboratories

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Lonza

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  STEMCELL Technologies Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Biovault Family

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  PromoCell GmbH

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Precision Cellular Storage Ltd.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample